title: Elvitegravir/cobicistat, mirabegron, and linaclotide.
authors.affiliation: Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, USA.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
authors.forename: Loren N
authors.initials: LN
authors.lastname: Martinez
mesh_terms: D000083:Acetanilides / Q000627:therapeutic use*; D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D002219:Carbamates / Q000627:therapeutic use*; D003248:Constipation / Q000188:drug therapy*; D003841:Deoxycytidine / Q000627:therapeutic use*; D004338:Drug Combinations; D000069545:Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D063065:Organophosphonates / Q000627:therapeutic use*; D010455:Peptides / Q000627:therapeutic use*; D015363:Quinolones / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*
chemical_list: D000083:Acetanilides; D044966:Anti-Retroviral Agents; D002219:Carbamates; D004338:Drug Combinations; D000069545:Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D063065:Organophosphonates; D010455:Peptides; D015363:Quinolones; D013844:Thiazoles; D003841:Deoxycytidine; D000225:Adenine; C520025:mirabegron; C523483:linaclotide